Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 2748152)

Published in Mitochondrion on June 27, 2009

Authors

Ruben K Dagda1, Jianhui Zhu, Charleen T Chu

Author Affiliations

1: Dept. of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, United States of America.

Articles citing this

Autophagy and the degradation of mitochondria. Mitochondrion (2010) 1.75

Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1. PLoS One (2010) 1.62

A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease. Hum Mol Genet (2010) 1.41

Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett (2010) 1.24

Mitochondria as a therapeutic target for aging and neurodegenerative diseases. Curr Alzheimer Res (2011) 1.17

Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis. J Bioenerg Biomembr (2009) 1.11

Tickled PINK1: mitochondrial homeostasis and autophagy in recessive Parkinsonism. Biochim Biophys Acta (2009) 1.09

The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease. Parkinsons Dis (2011) 1.07

Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease. Cell Death Differ (2011) 1.07

Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach. PLoS One (2011) 1.02

The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism. Int J Mol Sci (2012) 0.97

The protective role of 5-HMF against hypoxic injury. Cell Stress Chaperones (2010) 0.91

Drosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies. Parkinsons Dis (2011) 0.89

Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives. Pharmacol Ther (2014) 0.88

Computational deconvolution of genome wide expression data from Parkinson's and Huntington's disease brain tissues using population-specific expression analysis. Front Neurosci (2015) 0.88

ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression. Protein Cell (2013) 0.77

Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase. J Neural Transm (Vienna) (2011) 0.76

Pramipexole reduces phosphorylation of α-synuclein at serine-129. J Mol Neurosci (2013) 0.75

Articles cited by this

(truncated to the top 100)

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell (1997) 21.42

Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell (2005) 21.01

alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol (2008) 17.81

Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91

Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J (2008) 12.89

Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature (2006) 11.91

Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature (2006) 11.81

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science (1997) 9.58

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science (2004) 8.71

Molecular pathways of neurodegeneration in Parkinson's disease. Science (2003) 7.55

The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell (2004) 7.45

The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci U S A (2008) 7.41

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A (2005) 6.98

Mitochondria: more than just a powerhouse. Curr Biol (2006) 6.76

Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol (2005) 6.16

Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis (2006) 5.96

Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A (2006) 5.78

Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci (2007) 5.68

Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science (2000) 5.62

Autophagosome formation in mammalian cells. Cell Struct Funct (2002) 5.58

The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors (2006) 5.58

Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci U S A (2008) 4.97

Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem (2009) 4.90

Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron (2005) 4.87

Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep (2007) 4.73

Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol (2005) 4.67

Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci (2008) 4.63

The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol (2007) 4.60

Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A (2008) 4.50

The mechanism of Ca2+ -dependent regulation of kinesin-mediated mitochondrial motility. Cell (2009) 4.26

Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci U S A (2005) 4.22

Mitochondrial signaling: the retrograde response. Mol Cell (2004) 4.21

Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (1990) 4.03

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet (2006) 4.01

PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol (2007) 3.86

Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem (2008) 3.86

Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet (2005) 3.76

Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ (2003) 3.75

Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol (2006) 3.72

The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci U S A (2008) 3.65

Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol (2007) 3.61

Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci U S A (2007) 3.50

Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am J Pathol (2007) 3.29

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet (2005) 3.29

Drp-1-dependent division of the mitochondrial network blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated apoptosis. Mol Cell (2004) 3.28

Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy (2005) 3.27

Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest (2008) 3.23

The role of autophagy in mitochondria maintenance: characterization of mitochondrial functions in autophagy-deficient S. cerevisiae strains. Autophagy (2007) 3.14

Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem (2008) 3.08

Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci (2002) 2.83

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci U S A (2003) 2.74

Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69

Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci U S A (2008) 2.64

Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci U S A (2005) 2.58

Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J Neurosci (2007) 2.56

An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J Neurosci (2002) 2.54

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem (2008) 2.53

PINK1 protein in normal human brain and Parkinson's disease. Brain (2006) 2.49

Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage. J Biol Chem (2000) 2.44

Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry (2009) 2.38

PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS One (2008) 2.33

Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol (1999) 2.31

PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol (2004) 2.30

Characterization of PINK1 processing, stability, and subcellular localization. J Neurochem (2008) 2.29

Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res (2002) 2.28

Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem (2005) 2.26

Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol (1996) 2.22

N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci (2008) 2.18

Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem (2003) 2.15

A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther (2006) 2.10

Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc Natl Acad Sci U S A (2006) 2.08

Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem (2002) 2.07

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron (2001) 2.05

JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2004) 2.05

Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci U S A (2001) 1.98

Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radic Biol Med (2005) 1.93

DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci (2003) 1.90

Mitochondrial modulation: reversible phosphorylation takes center stage? Trends Biochem Sci (2005) 1.81

Oxidative neuronal injury. The dark side of ERK1/2. Eur J Biochem (2004) 1.81

Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp Neurol (2000) 1.80

Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis (2006) 1.78

Mitochondrial fission is an upstream and required event for bax foci formation in response to nitric oxide in cortical neurons. Cell Death Differ (2006) 1.77

Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol (2003) 1.75

Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease. Autophagy (2008) 1.74

Mitochondrial DNA deletions inhibit proteasomal activity and stimulate an autophagic transcript. Free Radic Biol Med (2006) 1.73

The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro. J Neurochem (2009) 1.71

A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases. J Cell Sci (2007) 1.70

Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun (2005) 1.64

Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum Mol Genet (2004) 1.61

Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J Neurosci (2000) 1.59

Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy (2007) 1.55

JNK signalling: a possible target to prevent neurodegeneration. Curr Pharm Des (2007) 1.53

Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proc Natl Acad Sci U S A (2006) 1.51

Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci U S A (2005) 1.48

Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease. J Neurochem (2001) 1.47

Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A (2001) 1.45

c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons. J Neurochem (2007) 1.44

High levels of Fis1, a pro-fission mitochondrial protein, trigger autophagy. Biochim Biophys Acta (2008) 1.44

Articles by these authors

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem (2009) 4.90

Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem (2008) 3.86

Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am J Pathol (2007) 3.29

Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA (2008) 3.16

Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation (2002) 3.09

A comprehensive glossary of autophagy-related molecules and processes (2nd edition). Autophagy (2011) 2.02

Bioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarization. Hum Mol Genet (2010) 1.99

Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol (2007) 1.95

Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radic Biol Med (2005) 1.93

Regulation of the autophagy protein LC3 by phosphorylation. J Cell Biol (2010) 1.86

Beclin 1-independent pathway of damage-induced mitophagy and autophagic stress: implications for neurodegeneration and cell death. Autophagy (2007) 1.79

Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol (2003) 1.75

Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease. Autophagy (2008) 1.74

Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice. J Am Coll Cardiol (2003) 1.74

The potential role of resistin in atherogenesis. Atherosclerosis (2005) 1.62

Mitochondrial aberrations in mucolipidosis Type IV. J Biol Chem (2006) 1.61

In vivo effects of single intra-articular injection of 0.5% bupivacaine on articular cartilage. J Bone Joint Surg Am (2010) 1.59

Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53. J Biol Chem (2003) 1.56

Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy (2007) 1.55

The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63. J Biol Chem (2005) 1.49

Starving neurons show sex difference in autophagy. J Biol Chem (2008) 1.49

Adiponectin and coronary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol (2005) 1.45

Isolation and characterization of fourteen novel putative and nine known target genes of the p53 family. Cancer Biol Ther (2003) 1.45

Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases. Am J Pathol (2002) 1.43

A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methods. Int J Circumpolar Health (2005) 1.43

Insights into the role of infection in atherogenesis and in plaque rupture. Circulation (2009) 1.39

Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester. J Cereb Blood Flow Metab (2007) 1.33

6-Hydroxydopamine induces mitochondrial ERK activation. Free Radic Biol Med (2007) 1.32

Hippocampal long-term potentiation, memory, and longevity in mice that overexpress mitochondrial superoxide dismutase. Neurobiol Learn Mem (2006) 1.32

Autophagy in neuroprotection and neurodegeneration: A question of balance. Future Neurol (2008) 1.31

Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells. J Biol Chem (2006) 1.25

Optical coherence tomography grading correlates with MRI T2 mapping and extracellular matrix content. J Orthop Res (2010) 1.23

Nuclear transport, oxidative stress, and neurodegeneration. Int J Clin Exp Pathol (2011) 1.22

The p75 neurotrophin receptor can induce autophagy and death of cerebellar Purkinje neurons. J Neurosci (2004) 1.21

Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains. J Biol Chem (2005) 1.19

Arthroscopic microscopy of articular cartilage using optical coherence tomography. Am J Sports Med (2004) 1.17

After the banquet: mitochondrial biogenesis, mitophagy, and cell survival. Autophagy (2013) 1.17

Mitochondrial dysfunction in Parkinson's disease. J Alzheimers Dis (2010) 1.16

CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays. Mol Cell Proteomics (2011) 1.16

Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through protein kinase A. J Neurochem (2013) 1.16

Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons. Am J Pathol (2012) 1.16

Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology. J Proteome Res (2010) 1.15

Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. J Neurosci (2011) 1.13

Two novel hierarchical homogeneous nanoarchitectures of TiO2 nanorods branched and P25-coated TiO2 nanotube arrays and their photocurrent performances. Nanoscale Res Lett (2011) 1.12

Autophagy is increased in mice after traumatic brain injury and is detectable in human brain after trauma and critical illness. Autophagy (2007) 1.12

Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis. J Bioenerg Biomembr (2009) 1.11

A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease. Neurobiol Dis (2009) 1.11

Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS). Am Heart J (2006) 1.08

PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. J Clin Invest (2014) 1.06

ATP13A2 regulates mitochondrial bioenergetics through macroautophagy. Neurobiol Dis (2011) 1.06

Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. J Proteome Res (2014) 1.04

Effects of acute mental stress and exercise on inflammatory markers in patients with coronary artery disease and healthy controls. Am J Cardiol (2008) 1.02

Role of reactive oxygen species in extracellular signal-regulated protein kinase phosphorylation and 6-hydroxydopamine cytotoxicity. J Biosci (2003) 1.02

C-Reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: insights from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. Diabetes Care (2008) 1.01

Analysis of glycan variation on glycoproteins from serum by the reverse lectin-based ELISA assay. J Proteome Res (2014) 1.00

Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study. Atherosclerosis (2008) 0.98

It's a cell-eat-cell world: autophagy and phagocytosis. Am J Pathol (2013) 0.95

Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease. J Biol Chem (2009) 0.94

Intracranial extramedullary hematopoiesis associated with pilocytic astrocytoma: a case report. Acta Neuropathol (2003) 0.94

p73 can suppress the proliferation of cells that express mutant p53. Oncogene (2003) 0.93

Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion. Cardiovasc Res (2013) 0.93

Monitoring mitophagy in neuronal cell cultures. Methods Mol Biol (2011) 0.93

Lipoprotein-associated phospholipase A(2) mass and activity and risk of cardiovascular disease in a population with high prevalences of obesity and diabetes: the Strong Heart Study. Diabetes Care (2012) 0.91

Platinum(II) compounds bearing bone-targeting group: synthesis, crystal structure and antitumor activity. Chem Commun (Camb) (2010) 0.91

Prevalence and correlates of subclinical atherosclerosis in Alaska Eskimos: the GOCADAN study. Stroke (2008) 0.90

Mitochondrial autophagy as a compensatory response to PINK1 deficiency. Autophagy (2009) 0.89

A novel fluorescent probe for the detection of nitric oxide in vitro and in vivo. Free Radic Biol Med (2008) 0.89

Synaptic dysfunction in genetic models of Parkinson's disease: a role for autophagy? Neurobiol Dis (2010) 0.88

To eat or not to eat: neuronal metabolism, mitophagy, and Parkinson's disease. Antioxid Redox Signal (2011) 0.87

IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis. Atherosclerosis (2003) 0.87

Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma. J Proteome Res (2014) 0.86

A trinuclear copper(II) complex of 2,4,6-tris(di-2-pyridylamine)-1,3,5-triazine shows prominent DNA cleavage activity. Inorg Chem (2007) 0.86

Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays. J Proteome Res (2014) 0.84

Immunohistochemical staining, laser capture microdissection, and filter-aided sample preparation-assisted proteomic analysis of target cell populations within tissue samples. Electrophoresis (2013) 0.84

Isobaric protein-level labeling strategy for serum glycoprotein quantification analysis by liquid chromatography-tandem mass spectrometry. Anal Chem (2013) 0.84

Chordoid glioma: a case report and molecular characterization of five cases. Brain Pathol (2008) 0.84

Human mesenchymal stem cells/multipotent stromal cells consume accumulated autophagosomes early in differentiation. Stem Cell Res Ther (2014) 0.83

Facile fabrication of hierarchical ZnCo2O4/NiO core/shell nanowire arrays with improved lithium-ion battery performance. Nanoscale (2014) 0.82

Large-scale uniform α-Co(OH)₂ long nanowire arrays grown on graphite as pseudocapacitor electrodes. ACS Appl Mater Interfaces (2010) 0.82

Beyond mitophagy: cytosolic PINK1 as a messenger of mitochondrial health. Antioxid Redox Signal (2015) 0.82

Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. J Clin Hypertens (Greenwich) (2012) 0.81

Acanthamoeba keratitis: a clinicopathologic case report and review of the literature. Hum Pathol (2013) 0.80

Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN study. Genet Epidemiol (2013) 0.80

B lymphocytes as effector cells in the immunotherapy of cancer. J Surg Oncol (2011) 0.79

Nitrogen and sulfur codoped graphene: multifunctional electrode materials for high-performance li-ion batteries and oxygen reduction reaction. Adv Mater (2014) 0.79

Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes. Apoptosis (2011) 0.79

Altered transcription factor trafficking in oxidatively-stressed neuronal cells. Biochim Biophys Acta (2012) 0.78

Autophagy in different flavors: dysregulated protein degradation in neurological diseases. Neurobiol Dis (2011) 0.78

PrimerCE: designing primers for cloning and gene expression. Mol Biotechnol (2010) 0.78

Oxidative DNA cleavage promoted by multinuclear copper complexes: activity dependence on the complex structure. Chemistry (2006) 0.77

A positively charged trinuclear 3N-chelated monofunctional platinum complex with high DNA affinity and potent cytotoxicity. Dalton Trans (2006) 0.77

Mitochondria and Parkinson's disease. Parkinsons Dis (2012) 0.76

Diffusion-controlled evolution of core-shell nanowire arrays into integrated hybrid nanotube arrays for Li-ion batteries. Nanoscale (2013) 0.76